CRON(Cronos Group Inc.) 的财务报表:医疗保健,特药与仿制药。数据来自 SEC 公开申报与市场行情,不构成投资建议。
| 科目 | FY 截至 2021-12-31 | FY 截至 2022-12-31 | FY 截至 2023-12-31 | FY 截至 2024-12-31 | FY 截至 2025-12-31 |
|---|---|---|---|---|---|
| 营业收入 | $64.56M | $86.75M | $87.24M | $117.61M | $146.59M |
| 毛利润 | −$17.59M | $15.44M | $11.91M | $25.20M | $62.76M |
| 营业利润 | −$291.97M | −$111.43M | −$84.80M | −$76.53M | −$17.39M |
| 净利润 | −$396.11M | −$168.73M | −$73.96M | $41.08M | −$9.45M |
| 经营现金流 | −$153.62M | −$88.95M | −$42.84M | $18.84M | $25.87M |
| 自由现金流 | −$164.76M | −$92.40M | −$45.34M | $6.43M | $149.00K |
| 摊薄每股收益 | $-1.07 | $-0.45 | $-0.19 | $0.11 | $-0.02 |